Pharmaceutical giant GlaxoSmithKline Pakistan Limited (GSK Pakistan) has announced the appointment of Dmytro Oliinyk, VP Head of Finance, International Region of GlaxoSmithKline, as Non-Executive Director and Chairperson of the company. The appointment was disclosed in a notice to the Pakistan Stock Exchange (PSX) on Tuesday.
Read More: Gold Holds Ground While Middle East Tensions Push Oil Higher as Hormuz Deadline Approaches
Dmytro Oliinyk will fill the casual vacancy created by the resignation of Lai Kuen Goh from the Board of Directors of GlaxoSmithKline Pakistan Limited.
About Dmytro Oliinyk
Dmytro Oliinyk serves as Vice President, Head of Finance for the International Region of GlaxoSmithKline. His extensive experience in global pharmaceutical finance and strategic leadership brings valuable expertise to the board of GSK Pakistan.
About GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited was incorporated in Pakistan as a limited liability company and is engaged in the manufacturing and marketing of research-based ethical specialities and pharmaceutical products. The company is a subsidiary of S.R. One International B.V. , incorporated in the Netherlands, while its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc) .
The company has a long-standing presence in Pakistan’s pharmaceutical sector, providing high-quality medicines, vaccines, and consumer healthcare products to patients and healthcare providers across the country.
About GSK plc
GlaxoSmithKline plc (GSK plc) is a global biopharmaceutical company headquartered in the United Kingdom, committed to uniting science, technology, and talent to get ahead of disease together. GSK has a significant global footprint and is one of the world’s leading pharmaceutical companies.
